Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.565
-0.030 (-0.65%)
May 18, 2026, 4:18 PM CET
Faes Farma Revenue
Faes Farma had revenue of 200.07M EUR in the quarter ending March 31, 2026, with 30.77% growth. This brings the company's revenue in the last twelve months to 674.06M, up 28.63% year-over-year. In the year 2025, Faes Farma had annual revenue of 626.99M with 22.93% growth.
Revenue (ttm)
674.06M
Revenue Growth
+28.63%
P/S Ratio
2.12
Revenue / Employee
251.61K
Employees
2,681
Market Cap
1.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 626.99M | 116.95M | 22.93% |
| Dec 31, 2024 | 510.04M | 36.95M | 7.81% |
| Dec 31, 2023 | 473.09M | 11.38M | 2.46% |
| Dec 31, 2022 | 461.72M | 33.08M | 7.72% |
| Dec 31, 2021 | 428.64M | 17.15M | 4.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.44B |
| Almirall | 1.12B |
| Laboratorios Farmaceuticos Rovi | 741.09M |
| Laboratorio Reig Jofre | 335.01M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 251.89M |
| Pharma Mar | 225.43M |
| Atrys Health | 144.31M |
Faes Farma News
- 18 days ago - Faes Farma Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Faes Farma Earnings Call Transcript: Q4 2025 - Transcripts
- 1 year ago - Faes Farma Transcript: M&A Announcement - Transcripts
- 1 year ago - Faes Farma Transcript: CMD 2025 - Transcripts